The Proangiogenic Capabilities of Malignant Ascites Generated by Aggressive Ovarian Tumors
Concentration of soluble proangiogenic agents in conditioned medium harvested from endothelial cells exposed to benign peritoneal ascites and to malignant ascites from patients with clear cell, endometrioid, serous, and undifferentiated ovarian cancer.
Soluble factor (pg/105 cells)
Type I cancers
Type II cancers
The results derive from an analysis of tumors from 8 different patients per group and are expressed as mean ± SEM. versus benign fluids; versus clear cell; versus endometrioid; versus serous.
Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.